Jason Bahl

Jason Bahl is a marketing research and analytics lead at Paratek Pharmaceuticals, focusing on customer insights and strategic planning for the potential launch of omadacycline. With extensive experience in pharmaceutical marketing, Jason has previously served as Sr. Director & Head of Customer Insights & Portfolio Development at Lundbeck, leading multiple teams to optimize asset value and drive impactful market insights. Jason held various roles at Pfizer, including Director of External Opportunities & Alliance Management, where contributions supported strategic business development in renal and rare disease therapy areas, and Director of Global Strategic Forecasting, managing long-term forecasts exceeding $7.5 billion. Early career experience includes senior financial report analysis at the Federal Reserve Bank of Philadelphia. Jason holds an MBA in Economics from Temple University and a Bachelor of Science in Mathematical Sciences from Villanova University.